前列腺动脉栓塞术后排尿与储尿症状域评分结局
尿潴留患者84%通过排尿试验,排尿域评分持续低于储尿域。
要点
- PAE可有效改善BPH相关LUTS和尿潴留,疗效持续至36个月。
- LUTS患者PAE后排尿域改善程度显著大于储尿域。
- 尿潴留患者PAE后84%通过排尿试验,排尿域评分低于储尿域。
核心结论
- PAE能有效治疗BPH相关LUTS和尿潴留,排尿域症状改善优于储尿域并维持至36个月。
主要发现
- 可评估LUTS患者(n=147)IPSS总分至36个月持续改善(6.3±4.2至8.6±7.6),QoL亦改善(1.1±1.1至1.8±1.5)。
- PAE后1个月IPSS排尿域改善69%±29%,大于储尿域的46%±33%(P<.000001),至36个月仍更优(68%±31% vs 53%±28%,P=.004)。
- 可评估尿潴留患者(n=75)中84%通过排尿试验,IPSS总分(6.0±3.9至8.2±6.7)和QoL(0.9±1.2至1.5±1.6)至36个月维持低水平。
- 尿潴留患者PAE后1个月排尿域平均分0.9±1.3低于储尿域1.7±1.4(P=.003),至24个月仍更低(0.9±1.2 vs 1.3±1.1,P=.02),36个月趋势相似(0.7±1.1 vs 1.1±1.1,P=.07)。
临床怎么用
- PAE可作为BPH相关LUTS或尿潴留的治疗选择,尤其对排尿症状为主者可能获益更明显。
- 术后应分别评估排尿域和储尿域症状,储尿域改善相对较慢,需合理管理患者预期。
局限性
- 单中心研究,部分患者失访(LUTS可评估147/161,尿潴留可评估75/79),36个月数据有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To characterize voiding and storage symptom domain-specific outcomes after prostate artery embolization (PAE) to treat lower urinary tract symptoms (LUTS) or urinary retention caused by benign prostatic hyperplasia (BPH). METHODS: Two hundred forty patients (age = 74.5 ± 8.6 years) underwent PAE between May 2013 and March 2020 at a single center for LUTS (n = 161) or urinary retention (n = 79). Total International Prostate Symptom Score (IPSS-t), voiding domain score (IPSS-v), storage domain score (IPSS-s), and Quality of Life score (QoL) were obtained pre-PAE for LUTS patients (IPSS-t = 21.7 ± 6.2, IPSS-v = 11.9 ± 4.3, IPSS-s = 9.6 ± 3.1, QoL = 4.5 ± 1.2), and post-PAE through 36 months (mean = 22.9 ± 15.2 months) for LUTS and retention patients. Mean relative changes in IPSS-t, IPSS-v, IPSS-s, and QoL were calculated for LUTS patients. Mean voiding or storage component scores were calculated for retention patients. RESULTS: For evaluable LUTS patients (n = 147), IPSS-t showed sustained substantial improvement through 36 months (6.3 ± 4.2-8.6 ± 7.6), as did QoL (1.1 ± 1.1-1.8 ± 1.5). One month after PAE, improvements in IPSS-v (69% ± 29%) were greater than in IPSS-s (46% ± 33%; P < .000001), and remained so through 36 months (68% ± 31% vs 53% ± 28%, P = .004). Among evaluable retention patients (n = 75), 84% passed voiding trials. Both IPSS-t (6.0 ± 3.9-8.2 ± 6.7) and QoL (0.9 ± 1.2-1.5 ± 1.6) remained low through 36 months. One month after PAE, mean IPSS-v component score (0.9 ± 1.3) was lower than mean IPSS-s component score (1.7 ± 1.4; P = .003) and remained so through 24 months (0.9 ± 1.2 vs 1.3 ± 1.1, P = .02), with similar trend at 36 months (0.7 ± 1.1 vs 1.1 ± 1.1, P = .07). CONCLUSIONS: PAE effectively treated BPH-related LUTS and retention. IPSS-v improved more than IPSS-s in LUTS patients, and remained lower in LUTS and retention patients through 36 months.
引用
- Powell T, Staib L, Liu B, et al. Voiding and Storage Domain-Specific Symptom Score Outcomes After Prostate Artery Embolization for Lower Urinary Tract Symptoms and Urinary Retention. Urology. 2021. PMID: 33961894. doi:10.1016/j.urology.2021.02.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。